|
  • Registar
  • Entrar
  • pt_PT
    en English es Español
    MLSHN

    Publique um artigo científico

    em inglês, espanhol ou português!

    Submit article illustration
    • Atual
    • Arquivos
    • Sobre
      • Sobre a Revista
      • Equipa Editorial
      • Revisores
      • Estatísticas
    • Submissões
    • Indexação
    • Contactar-nos

    Akkermansia muciniphila, a bacteria against obesity and its relationship with diet. Systematic review

    Publicado 2024-05-22

    DOI:

    https://doi.org/10.60134/mlshn.v3n1.2741

    Cintia Amaral Montesino

    ORCID http://orcid.org/0000-0002-8119-6046

    Formatos Disponíveis

    HTML

    es

    EPUB

    es

    HTML

    en

    EPUB

    en

    Número do Artigo

    Vol. 3 N.º 1 (2024)

    ISSN: 2952-2471

    Publicado: 2024-05-30

    Resumo

    The anaerobic bacterium Akkermansia muciniphila has demonstrated its role in regulating metabolism and markers of inflammation since its discovery. It is a Gram-negative bacteria that is classified within the phylum Verrucomicrobiae. It is recognized as a non-pathogenic bacteria, devoid of virulence factors and lacking a significant interaction with the host that leads to infection or disease. It is part of the human intestinal microbiome and its highest concentration is found in individuals of normal weight. A systematic review was performed to analyze clinical dietary interventions examining the association between obesity phenotype or status and the concentration of A. muciniphila in the intestinal microbiota, after specific nutritional modifications in overweight human patients. The search for articles was carried out using Pubmed and Clinicalkey as search engines. The Boolean terminology ((Akkermansia muciniphila) and (obesity)) and (intervention or nutrition or diet or nutrient) was used to select articles relevant to our research. Of the 301 original articles identified, only those involving dietary interventions in humans were selected. The results indicate that increasing A. muciniphila (either through direct supplementation or dietary intervention) was associated with beneficial effects such as decreased inflammation, reduced cardiovascular risk, increased insulin sensitivity, and reduced cholesterol levels. In conclusion, further interventions in humans are needed to determine the benefits and risks of increasing A. muciniphila concentrations.


    Downloads

    Os dados de download ainda não estão disponíveis.

    Estatísticas


    Cómo citar

    • ACM
    • ACS
    • APA
    • ABNT
    • Chicago
    • Harvard
    • IEEE
    • MLA
    • Turabian
    • Vancouver
    • AMA
    Akkermansia muciniphila, a bacteria against obesity and its relationship with diet. Systematic review. (2024). MLS Health and Nutrition Research, 3(1). https://doi.org/10.60134/mlshn.v3n1.2741
    EndNote Zotero Mendeley
    Transferir .ris .ris
    EndNote
    Transferir .bib

    Citações

    1. Guyton AC, John Edward Hall. Textbook of Medical Physiology. Saunders; 2006.

    2. Servin AL. Antagonistic Activities of Lactobacilli and Bifidobacteria against Microbial Pathogens. FEMS Microbiology Reviews. 2004 Oct;28(4):405–40.

    3. Vitale M, Giacco R, Laiola M, Della Pepa G, Luongo D, Mangione A, et al. Acute and Chronic Improvement in Postprandial Glucose Metabolism by a Diet Resembling the Traditional Mediterranean Dietary pattern: Can SCFAs Play a role? Clinical Nutrition. 2021 Feb;40(2):428–37.

    4. Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, et al. Cross-talk between Akkermansia Muciniphila and Intestinal Epithelium Controls diet-induced Obesity. Proceedings of the National Academy of Sciences. 2013 May 13;110(22):9066–71.

    5. Shen J, Tong X, Sud N, Khound R, Song Y, Maldonado-Gomez MX, et al. Low-Density Lipoprotein Receptor Signaling Mediates the Triglyceride-Lowering Action of Akkermansia Muciniphila in Genetic-Induced Hyperlipidemia. Arteriosclerosis, Thrombosis, and Vascular Biology. 2016 Jul;36(7):1448–56.

    6. Dao MC, Everard A, Aron-Wisnewsky J, Sokolovska N, Prifti E, Verger EO, et al. Akkermansia Muciniphila and Improved Metabolic Health during a Dietary Intervention in obesity: Relationship with Gut Microbiome Richness and Ecology. Gut. 2015 Jun 22;65(3):426–36.

    7. Depommier C, Everard A, Druart C, Plovier H, Van Hul M, Vieira-Silva S, et al. Supplementation with Akkermansia Muciniphila in Overweight and Obese Human volunteers: a proof-of-concept Exploratory Study. Nature Medicine. 2019 Jul;25(7):1096–103.

    8. Roshanravan N, Bastani S, Tutunchi H, Kafil B, Nikpayam O, Mesri Alamdari N, et al. A Comprehensive Systematic Review of the Effectiveness of Akkermansia muciniphila, a Member of the Gut microbiome, for the Management of Obesity and Associated Metabolic Disorders. Archives of Physiology and Biochemistry. 2021 Jan 15;129(3):1–11.

    9. Mujico JR, Baccan GC, Gheorghe A, Díaz LE, Marcos A. Changes in Gut Microbiota Due to Supplemented Fatty Acids in diet-induced Obese Mice. The British Journal of Nutrition [Internet]. 2013 Aug 1 [cited 2023 Jun 6];110(4):711–20. Available from: https://pubmed.ncbi.nlm.nih.gov/23302605/

    10. Abuqwider JN, Mauriello G, Altamimi M. Akkermansia muciniphila, a New Generation of Beneficial Microbiota in Modulating Obesity: a Systematic Review. Microorganisms. 2021 May 20;9(5):1098.

    11. Medina-Larqué AS, Rodríguez-Daza MC, Roquim M, Dudonné S, Pilon G, Levy É, et al. Cranberry Polyphenols and Agave Agavins Impact Gut Immune Response and Microbiota Composition While Improving Gut Barrier function,

    inflammation, and Glucose Metabolism in Mice Fed an Obesogenic Diet. Frontiers in Immunology. 2022 Aug 16;13.

    12. Zhang T, Li Q, Cheng L, Buch H, Zhang F. Akkermansia Muciniphila Is a Promising Probiotic. Microbial Biotechnology. 2019 Apr 21;12(6):1109–25.

    13. Derrien M, Belzer C, de Vos WM. Akkermansia Muciniphila and Its Role in Regulating Host Functions. Microbial Pathogenesis. 2017 May;106:171–81.

    14. Depommier C, Vitale RM, Iannotti FA, Silvestri C, Flamand N, Druart C, et al. Beneficial Effects of Akkermansia Muciniphila Are Not Associated with Major Changes in the Circulating Endocannabinoidome but Linked to Higher Mono-Palmitoyl-Glycerol Levels as New PPARα Agonists. Cells. 2021 Jan 19;10(1):185.

    15. Bian X, Wu W, Yang L, Lv L, Wang Q, Li Y, et al. Administration of Akkermansia Muciniphila Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice. Frontiers in Microbiology. 2019 Oct 1;10.

    16. Qian K, Chen S, Wang J, Sheng K, Wang Y, Zhang M. A β-N-acetylhexosaminidase Amuc_2109 from Akkermansia Muciniphila Protects against Dextran Sulfate Sodium-induced Colitis in Mice by Enhancing Intestinal Barrier and Modulating Gut Microbiota. Food & Function. 2022;4.

    17. Rodrigues VF, Elias-Oliveira J, Pereira ÍS, Pereira JA, Barbosa SC, Machado MSG, et al. Akkermansia Muciniphila and Gut Immune System: a Good Friendship That Attenuates Inflammatory Bowel Disease, Obesity, and Diabetes. Frontiers in Immunology [Internet]. 2022 Jul 7;13. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300896/pdf/fimmu-13-934695.pdf

    18. Ashrafian F, Shahriary A, Behrouzi A, Moradi HR, Keshavarz Azizi Raftar S, Lari A, et al. Akkermansia muciniphila-Derived Extracellular Vesicles as a Mucosal Delivery Vector for Amelioration of Obesity in Mice. Frontiers in Microbiology. 2019 Oct 1;10.

    19. Chelakkot C, Choi Y, Kim DK, Park HT, Ghim J, Kwon Y, et al. Akkermansia muciniphila-derived Extracellular Vesicles Influence Gut Permeability through the Regulation of Tight Junctions. Experimental & Molecular Medicine. 2018 Feb;50(2):e450–0.

    20. Druart C, Plovier H, Van Hul M, Brient A, Phipps KR, Vos WM, et al. Toxicological Safety Evaluation of Pasteurized Akkermansia Muciniphila. Journal of Applied Toxicology. 2020 Jul 28;41(2):276–90.

    21. Tagliamonte S, Laiola M, Ferracane R, Vitale M, Gallo MA, Meslier V, et al. Mediterranean Diet Consumption Affects the Endocannabinoid System in Overweight and Obese subjects: Possible Links with Gut microbiome, Insulin Resistance and Inflammation. European Journal of Nutrition. 2021 Mar 24;60.

    22. Walker JM, Eckardt P, Aleman JO, Correa J, Liang Y, Tadasu Iizumi, et al. The effects of trans-resveratrol on insulin resistance, inflammation, and microbiota in men with the metabolic syndrome: A pilot randomized, placebo-controlled clinical trial. PubMed. 2019 Jan 10;4(2):122–35.

    23. Xu D, Feng M, Chu Y, Wang S, Shete V, Tuohy KM, et al. The Prebiotic Effects of Oats on Blood Lipids, Gut Microbiota, and Short-Chain Fatty Acids in Mildly Hypercholesterolemic Subjects Compared with Rice: a Randomized, Controlled Trial. Frontiers in Immunology [Internet]. 2021 Dec 9;12:787797. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697019/

    24. Jie Z, Yu X, Liu Y, Sun L, Chen P, Ding Q, et al. The Baseline Gut Microbiota Directs Dieting-Induced Weight Loss Trajectories. Gastroenterology [Internet]. 2021 May 1 [cited 2022 Oct 14];160(6):2029-2042.e16. Available from: https://www.gastrojournal.org/article/S0016-5085(21)00096-2/fulltext

    25. Wright SM, Aronne LJ. Causes of Obesity. Abdominal Radiology [Internet]. 2012 Mar 18;37(5):730–2. Available from: https://link.springer.com/article/10.1007/s00261-012-9862-x

    26. Netto Candido TL, Alfenas R de CG, Bressan J. Dysbiosis and Metabolic Endotoxemia Induced by high-fat Diet. Nutrición Hospitalaria. 2018 Oct 17;35(6).

    27. Sun L, Ma L, Ma Y, Zhang F, Zhao C, Nie Y. Insights into the Role of Gut Microbiota in obesity: pathogenesis, mechanisms, and Therapeutic Perspectives. Protein & Cell [Internet]. 2018 May [cited 2019 Nov 4];9(5):397–403. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960470/

    28. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Human gut microbes associated with obesity. Nature [Internet]. 2006 Dec;444(7122):1022–3. Available from: https://www.nature.com/articles/4441022a

    29. Bibbò S, Ianiro G, Giorgio V, Scaldaferri F, Masucci L, Gasbarrini A, et al. The Role of Diet on Gut Microbiota Composition. European Review for Medical and Pharmacological Sciences [Internet]. 2016 Nov 1;20(22):4742–9. Available from: http://pubmed.ncbi.nlm.nih.gov/27906427

    30. Kankaanpää PE, Salminen SJ, Isolauri E, Lee YK. The Influence of Polyunsaturated Fatty Acids on Probiotic Growth and Adhesion. FEMS Microbiology Letters [Internet]. 2001 Jan;194(2):149–53. Available from: https://academic.oup.com/femsle/article/194/2/149/489490

    31. Rosendo-Silva D, Viana S, Carvalho E, Reis F, Paulo Matafome. Are Gut dysbiosis, Barrier disruption, and Endotoxemia Related to Adipose Tissue Dysfunction in Metabolic disorders? Overview of the Mechanisms Involved. Internal and Emergency Medicine. 2023 Apr 4;18.

    32. Patterson E, O’ Doherty RM, Murphy EF, Wall R, O’ Sullivan O, Nilaweera K, et al. Impact of Dietary Fatty Acids on Metabolic Activity and Host Intestinal Microbiota Composition in C57BL/6J Mice. British Journal of Nutrition. 2014 Feb 20;111(11):1905–17.

    33. de Wit N, Derrien M, Bosch-Vermeulen H, Oosterink E, Keshtkar S, Duval C, et al. Saturated Fat Stimulates Obesity and Hepatic Steatosis and Affects Gut Microbiota Composition by an Enhanced Overflow of Dietary Fat to the Distal Intestine. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2012 Sep 1;303(5):G589–99.

    34. Tidjani Alou M, Lagier JC, Raoult D. Diet Influence on the Gut Microbiota and Dysbiosis Related to Nutritional Disorders. Human Microbiome Journal. 2016 Sep;1:3–11.

    35. Roshanravan N, Mahdavi R, Alizadeh E, Ghavami A, Rahbar Saadat Y, Naimeh Mesri Alamdari, et al. The Effects of Sodium Butyrate and Inulin Supplementation on Angiotensin Signaling Pathway via Promotion of Akkermansia Muciniphila Abundance in Type 2 diabetes; a randomized, double-blind, placebo-controlled Trial. Journal of Cardiovascular and Thoracic Research. 2017 Nov 25;9(4):183–90.

    36. Payahoo L, Khajebishak Y, Alivand MR, Soleimanzade H, Alipour S, Barzegari A, et al. Investigation the Effect of Oleoylethanolamide Supplementation on the Abundance of Akkermansia Muciniphila Bacterium and the Dietary Intakes in People with obesity: a Randomized Clinical Trial. Appetite. 2019 Oct;141:104301.

    37. Guevara-Cruz M, Godinez-Salas ET, Mónica Sánchez-Tapia, Torres-Villalobos G, Pichardo-Ontiveros E, Rocío Guizar-Heredia, et al. Genistein Stimulates Insulin Sensitivity through Gut Microbiota Reshaping and Skeletal Muscle AMPK Activation in Obese Subjects. Open Diabetes Res Care. 2020 Mar 1;8(1):e000948–8.

    38. Łagowska K, Drzymała-Czyż S. A Low Glycemic Index, Energy-restricted Diet but Not Lactobacillus Rhamnosus Supplementation Changes Fecal short-chain Fatty Acid and Serum Lipid Concentrations in Women with Overweight or Obesity and Polycystic Ovary Syndrome. European Review for Medical and Pharmacological Sciences [Internet]. 2022 Feb 1 [cited 2023 Apr 30];26(3):917–26. Available from: https://pubmed.ncbi.nlm.nih.gov/35179758/

    39. Netea MG, Domínguez-Andrés J, Barreiro LB, Chavakis T, Divangahi M, Fuchs E, et al. Defining Trained Immunity and Its Role in Health and Disease. Nature Reviews Immunology. 2020 Mar 4;20(6):375–88.

    40. Bäck M, Yurdagul A, Tabas I, Öörni K, Kovanen PT. Inflammation and Its Resolution in atherosclerosis: Mediators and Therapeutic Opportunities. Nature Reviews Cardiology [Internet]. 2019 Mar 7;16(7). Available from: https://www.nature.com/articles/s41569-019-0169-2

    41. Guevara-Cruz M, Godinez-Salas ET, Mónica Sánchez-Tapia, Torres-Villalobos G, Pichardo-Ontiveros E, Rocío Guizar-Heredia, et al. Genistein Stimulates Insulin Sensitivity through Gut Microbiota Reshaping and Skeletal Muscle AMPK Activation in Obese Subjects. Open Diabetes Res Care. 2020 Mar 1;8(1):e000948–8.

    42. Pogue A, Jaber I, Zhao Y, Lukiw W. Systemic Inflammation in C57BL/6J Mice Receiving Dietary Aluminum Sulfate; Up-Regulation of the Pro-Inflammatory Cytokines IL-6 and TNFα, C-Reactive Protein (CRP) and miRNA-146a in Blood Serum. Journal of Alzheimer’s Disease & Parkinsonism. 2017;07(06).

    43. Ouyang J, Lin J, Isnard S, Fombuena B, Peng X, Marette A, et al. The Bacterium Akkermansia muciniphila: a Sentinel for Gut Permeability and Its Relevance to HIV-Related Inflammation. Frontiers in Immunology. 2020 Apr 9;11.

    44. Rodríguez-Daza MC, de Vos WM. Polyphenols as Drivers of a Homeostatic Gut Microecology and Immuno-Metabolic Traits of Akkermansia muciniphila: from Mouse to Man. International Journal of Molecular Sciences. 2022 Dec 20;24(1):45.

    45. Cao MZ, Wei CH, Wen MC, Song Y, Srivastava K, Yang N, et al. Clinical Efficacy of Weight Loss Herbal Intervention Therapy and Lifestyle Modifications on Obesity and Its Association with Distinct Gut microbiome: a Randomized double-blind Phase 2 Study. Frontiers in Endocrinology. 2023 Mar 22;14


    Avisos

    2025-04-12

    Actualización OJS

    Ver mais

    Pesquisar documentos

    Título

    Autor

    Resumo

    Bolsas

    pt_PT

    Projetos I&D

    Proyectos i+D

    Notícias

    Noticias
    EU Flag

    Contato

    Parque Científico y Tecnológico de Cantabria. C/Isabel Torres 21.

    39011 Santander, Espanha.

    © 2025 Multi-Lingual Scientific (MLS) Journals. Todos os direitos reservados. | Política de privacidade | Transparência